Sarcoma surgery in Italy typically costs between $35,000 and $65,000. Prices depend on the cancer stage, surgical complexity, and the city. In the US, similar procedures cost around $200,000 on average. Patients save around 75% compared to US rates. The cost usually covers the surgery and standard hospital stay in major hubs like Rome or Milan.
Bookimed Expert Insight: Italy offers high-tech oncology at regional prices. Ospedale San Carlo di Nancy in Rome is a prime example. Patients there access the Da Vinci robotic system for complex tumor removals. This clinic serves 14,000 patients annually and holds top Bookimed rankings. Choosing a JCI-accredited facility in Rome ensures elite standards without the premium prices of Milan.
Why choose Italy for sarcoma surgery?
Access advanced Sarcoma surgery solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Sarcoma surgery | from $35,000 | from $10,000 | from $35,000 |
| Complex treatment of Ewing's sarcoma | from $40,000 | from $30,000 | from $55,000 |
| Leiomyosarcoma Removal | from $14,500 | - | - |
No hidden fees – just official clinic prices. Pay at the clinic for Sarcoma surgery upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Sarcoma surgery and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Sarcoma surgery journey.
Day 1: Arrival
Day 2: Pre-operation
Day 3: Surgery
Day 4-7: Post-operation
Week 1-2: Rehabilitation
Week 3-6: Further Rehabilitation
Week 7 onwards: Final Result
Please note that each patient"s case is individual, and the timeline can vary based on the specifics of your condition and recovery rate.
The doctor is a distinguished general surgeon with a specialization in Oncology and General Surgery, boasting 35 years of experience. The primary focus is on minimally invasive colorectal surgeries, proctological, and pelvic floor surgery. An active researcher and prolific author, the doctor participates in numerous healthcare projects related to colorectal cancer surgeries.
Graduating with distinction in Medicine and Surgery from the University of Rome 'La Sapienza', the doctor further specialized in General Surgery and Colorectal Surgery at prestigious institutions.
The best hospitals for sarcoma surgery in Italy include Istituto Nazionale dei Tumori in Milan and Istituto Ortopedico Rizzoli in Bologna. These facilities are primary national hubs within the Rete Nazionale Tumori Rari, specializing in complex retroperitoneal sarcomas and multidisciplinary musculoskeletal oncology.
Bookimed Expert Insight: While northern Italy dominates for bone sarcomas, central Italy offers strong alternatives for soft tissue cases. Ospedale San Carlo di Nancy in Rome treats 14,000 patients annually. Its integration with GVM Care & Research ensures standardized surgical protocols for rare tumor management in the capital.
Patient Consensus: Patients recommend contacting the Italian Sarcoma Group before finalizing a surgeon. Many suggest seeking centers in northern Italy for complex limb-sparing procedures to ensure better specialized team coordination.
To ensure optimal sarcoma surgery outcomes, ask your surgeon about their multidisciplinary approach and surgical margins. Confirm if they have specialty training in orthopedic or surgical oncology. You should also verify if a tumor board will review your specific sarcoma subtype pathology before the operation.
Bookimed Expert Insight: Italian centers often excel in limb-sparing techniques for complex cases. For example, Ospedale San Raffaele in Milan serves over 1.5 million patients annually. Their high volume suggests deep experience with rare tumor types that smaller clinics lack. Always ask if your surgeon frequently handles Ewing's sarcoma or similar aggressive subtypes.
Patient Consensus: Patients emphasize the relief found when surgeons clearly explain long-term monitoring plans. Many recommend asking about physical therapy early to manage expectations for post-operative mobility.
Italy prioritizes a centralized hub-and-spoke model for rare sarcomas, focusing on aggressive compartmental resection and organ-preserving techniques. Surgeons utilize frontline extended approaches for retroperitoneal tumors and intraoperative radiotherapy (IORT) to maximize local control while minimizing the risk of recurrence during complex resections.
Bookimed Expert Insight: Italian centers like Ospedale San Carlo di Nancy lead in robotic integration for gastrointestinal sarcomas. Our data shows that top Italian hubs specialize in organ-preserving protocols. Choosing a high-volume facility ensures access to specific techniques like cryoablation and IORT. These advanced options are rarely available in general surgical wards.
Patient Consensus: Patients emphasize seeking a national hub to prevent margin errors common at provincial hospitals. They often recommend arriving weeks early in Milan or Rome for specialized pathology reviews.
Italy offers specialized networks for sarcoma including the Italian Sarcoma Group (ISG) for medical professionals and the Fondazione Paola Gonzato for patients. These organizations connect patients with multidisciplinary care teams at recognized centers like the Istituto Nazionale dei Tumori in Milan.
Bookimed Expert Insight: While Italy has 19 clinics on our platform and hosts expert surgeons, formal support infrastructure is concentrated in Milan and Rome. Patients often find better immediate peer connectivity by contacting these major surgical hubs directly for informal survivor circles. This approach bridges the gap between official medical networks and the practical need for peer advice.
Patient Consensus: Since local meetups are limited, many patients utilize private WhatsApp groups or international Facebook communities for soft tissue sarcoma. They recommend contacting major oncology centers specifically for patient-led informal networks.